Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · DWS (Xtrackers)

DWS Health and Wellness Fund Class A (SUHAX)

Ticker SUHAX · Since 2000-12-29 · · Holdings as of May 31, 2026

Expense ratio
1.34%$134/yr per $10k
Net assets
$231.8Mall share classes
Holdings
65

Bottom line

Is SUHAX a good fund? The bottom line

SUHAX is the Class A share class of DWS Health and Wellness Fund, an actively managed health care sector mutual fund from DWS (Xtrackers).

Its expense ratio is 1.34% — about $134 a year on every $10,000 invested, more expensive than 76% of health care sector funds we track.

With $232 million in net assets and 65 holdings, its largest position is Eli Lilly & Co (13.9%) and the top 10 make up 51.3% of the portfolio.

This share class carries a front-end sales charge of up to 5.75%; a no-load class or ETF alternative can avoid it.

The closest lower-cost alternative we found is XLV (0.08%, 81% top-holdings overlap).

What to watch

  • Expensive for its category (1.34%)
  • Concentrated: top 10 holdings are 51.3% of assets
  • Front-end sales load up to 5.75%
  • 12b-1 marketing fee of 0.24% a year

Updated Nov 19, 2026

What SUHAX invests in

The fund seeks long-term growth of capital.

Main investments. Under normal circumstances, the fund invests at least 80% of net assets, plus the amount of any borrowings for investment purposes, in equity securities of companies in the health care and wellness sectors. For purposes of the funds 80% investment policy, to be considered part of the health care or wellness sectors, companies must commit at least half of their assets to, or derive at least half of their revenues or net income from, that sector. Industries in the health care sector include pharmaceuticals, biotechnology, medical products and supplies, and health care services. Portfolio management considers wellness-related companies to include companies in the health care industry and other companies that provide products or services that promote or aid in achieving a healthy lifestyle (for example, healthy food and nutrition companies and gym operators). The fund…

From the fund's prospectus (filed Sep 24, 2026).

SUHAX performance

Fund calendar-year total returns, 2015–2025 2015: +6.6%; 2016: −10.5%; 2017: +19.0%; 2018: +3.3%; 2019: +21.9%; 2020: +15.1%; 2021: +15.0%; 2022: −7.4%; 2023: +5.1%; 2024: +3.3%; 2025: +12.3% +7% 2015 −10% 2016 +19% 2017 +3% 2018 +22% 2019 +15% 2020 +15% 2021 −7% 2022 +5% 2023 +3% 2024 +12% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
SUHAX———
Health Care Sector median+14.5%+4.2%+7.9%

Source: Fund prospectus, as of

Full SUHAX performance history →

What SUHAX costs

On a $10,000 investment, SUHAX's 1.34% expense ratio costs about $134 a year. The prospectus estimates $2,095 in total costs over 10 years (assuming 5% annual returns). The median health care sector fund charges 0.96%.

See the full SUHAX fee table →

SUHAX top 10 holdings

#Holding% of fund
1Eli Lilly & Co13.85%
2Johnson & Johnson6.19%
3UnitedHealth Group Inc5.73%
4AbbVie Inc4.90%
5Merck & Co Inc4.85%
6AstraZeneca PLC3.80%
7Thermo Fisher Scientific Inc3.46%
8Novartis AG2.90%
9Amgen Inc2.88%
10Gilead Sciences Inc2.78%

Source: SEC Form N-PORT, period ended May 31, 2026

The top 10 make up 51.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to SUHAX

Closest equivalent at other fund companies
FamilyFundExpense ratioOverlap
SPDR (State Street)XLV State Street(R) Health Care Select…0.08%81% Compare
FidelityFHLC Fidelity MSCI Health Care Index ETF0.084%81% Compare
VanguardVHT Vanguard Health Care Index Fund0.09%79% Compare
iSharesIYH iShares U.S. Healthcare ETF0.37%76% Compare
J.P. MorganJDOC JPMorgan Healthcare Leaders ETF0.65%65% Compare
SchwabSWHFX Schwab Health Care Fund0.8%71% Compare

More funds like SUHAX →

SUHAX FAQ

What is the expense ratio of SUHAX?
SUHAX's expense ratio is 1.34%, which works out to about $134 a year for every $10,000 invested. The prospectus estimates total costs of $2,095 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is SUHAX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.34%); concentrated: top 10 holdings are 51.3% of assets; front-end sales load up to 5.75%; 12b-1 marketing fee of 0.24% a year. This is general information, not personalized advice.
What does SUHAX hold?
SUHAX's largest holdings are Eli Lilly & Co (13.9%), Johnson & Johnson (6.2%), UnitedHealth Group Inc (5.7%), AbbVie Inc (4.9%), Merck & Co Inc (4.9%). It holds 65 positions in total as of May 31, 2026 (SEC Form N-PORT).
Does SUHAX have a sales load?
Yes. SUHAX has a maximum front-end sales charge of 5.75%.
What is a cheaper alternative to SUHAX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) overlaps about 81% with SUHAX and charges 0.08%.
Who manages SUHAX?
SUHAX is offered by DWS (Xtrackers) through Deutsche Dws Securities Trust.